Free Trial
NYSE:PHIN

PHINIA Q2 2025 Earnings Report

PHINIA logo
$48.33 -0.03 (-0.06%)
Closing price 07/18/2025 03:59 PM Eastern
Extended Trading
$48.29 -0.04 (-0.08%)
As of 07/18/2025 05:24 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

PHINIA EPS Results

Actual EPS
N/A
Consensus EPS
$0.92
Beat/Miss
N/A
One Year Ago EPS
N/A

PHINIA Revenue Results

Actual Revenue
N/A
Expected Revenue
$836.51 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

PHINIA Announcement Details

Quarter
Q2 2025
Time
Before Market Opens
Conference Call Date
Thursday, July 24, 2025
Conference Call Time
8:30AM ET

Conference Call Resources

PHINIA Earnings Headlines

PHINIA Inc. (PHIN) - Yahoo Finance
A grave, grave error.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
See More PHINIA Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like PHINIA? Sign up for Earnings360's daily newsletter to receive timely earnings updates on PHINIA and other key companies, straight to your email.

About PHINIA

PHINIA (NYSE:PHIN) (NYSE: PHIN) is a global provider of advanced photonic and optical systems, specializing in the design, development and manufacture of precision laser, lighting and imaging solutions. Operating through two core divisions—Industrial Photonics and Clinical Imaging—PHINIA delivers a broad range of products that address high-performance applications in semiconductor manufacturing, materials processing, biomedical research and surgical guidance. The company’s vertically integrated engineering approach enables tight control over component quality, system integration and production timelines, positioning PHINIA as a trusted partner for customers seeking reliable, high-precision technologies.

The Industrial Photonics division offers diode and solid-state lasers, beam delivery optics, fiber-optic components and turnkey automation packages tailored to wafer inspection, PCB fabrication and additive manufacturing. Meanwhile, the Clinical Imaging segment develops portable and fixed imaging platforms, endoscopic cameras, surgical lighting systems and proprietary image-enhancement software used in hospitals, outpatient clinics and research laboratories. PHINIA’s products are backed by an expanding global service network that provides installation, calibration, training and on-site maintenance to help clients optimize uptime and throughput.

Founded in 2005 and headquartered in Boston, Massachusetts, PHINIA maintains manufacturing and R&D facilities in the United States, Germany and Singapore, complemented by regional sales offices in Japan, South Korea and Brazil. Over the past decade, the company has enhanced its product portfolio through strategic acquisitions of niche optics firms and in-house software developers, strengthening its end-to-end solution capabilities. PHINIA’s leadership team is led by CEO Dr. Emily Carter, who brings more than 20 years of photonics industry experience, alongside CFO Mark Johnson and CTO Dr. Alan Fein, both of whom have overseen key innovations in laser diode engineering and biomedical imaging technologies.

View PHINIA Profile

More Earnings Resources from MarketBeat